- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Nikki Reeves
News 17 results
In the News · Source: Law360 and The Colorado Sun
Recognition
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
Recognition
June 5, 2025
King & Spalding Earns 209 Lawyer Rankings, 100 Practice Group Rankings in Chambers USA Guide
Recognition
February 13, 2025
Chambers Global 2025 Recognizes King & Spalding as a Leading International Law Firm
Events 31 results
Webinar
January 28, 2026
Drug & Device Advertising Year in Review: Lessons from 2025 FDA Enforcement & Key Developments
Webinar
November 19, 2025
Prescription for Trouble: FDA’s “Crackdown” on Drug Ads
Conference
November 4, 2025
King & Spalding Pharmaceutical University 2025
Speaking Engagement
October 22, 2025
Rob DeConti, Nikki Reeves, John Shakow to Speak at the 26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress Conference
Insights 23 results
Client Alert
January 21, 2026
2025 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement
Client Alert
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
Article · Source: Legal 500 Country Comparative Guides 2025
December 9, 2025
United States: Pharmaceutical Advertising
Article · Source: Law360
October 6, 2025
Drug Ad Crackdown Demonstrates Admin's Aggressive Stance